Abstract:Key PointsInnate lymphoid cells (ILCs) are newly identified members of the lymphoid lineage with emerging roles in mediating immune responses and in regulating tissue homeostasis and inflammation.The existence of different ILC populations that can rapidly secrete immunoregulatory cytokines suggests that these cells may have evolved to provide immunity to infections. Indeed, it is notable that ILC subsets seem to be particularly prevalent at mucosal surfaces, which are constantly exposed to infectious agents in the external environment.The group 1 ILC lineage comprises ILCs such as natural killer (NK) cells that produce type 1 cytokines, notably interferon-γ and tumour necrosis factor. Other group 1 ILCs have been reported, mainly in vitro, and their physiological roles remain to be defined.The group 2 ILC population comprises ILC2s, which express interleukin-5 (IL-5) and IL-13 and require GATA-binding protein 3 (GATA3) and retinoic acid receptor-related orphan receptor-α (RORα) for their development. They have crucial roles in protective type 2 immunity to helminth infection. Furthermore, although T helper 2 cells are a major source of type 2 cytokines during allergic asthma, ILC2s also contribute to disease pathology.ILC3s were first defined as intestinal lymphoid cells that express the NK cell activating receptor NKp46, but otherwise bear little functional resemblance to conventional NK cells, and require RORγ for their development. They express IL-17A and IL-22.Recent studies have also implicated ILC3s in the development of inflammatory bowel disease. Studies in Rag2−/− mice demonstrated that, in the early phase of Citrobacter rodentium infection, IL-22 is produced from an innate cell source.Lymphoid tissue-inducer (LTi) cells are an ILC subset that appears to be closely related to ILC3s, but their exact relationship remains controversial. Together, LTi cells and ILC3s have been classified as group 3 ILCs.

RAG suppresses group 2 innate lymphoid cells

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

RAG-1-deficient mice have no mature B and T lymphocytes

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

RAG1 splicing mutation causes enhanced B cell differentiation and autoantibody production

The Transcription Factor RelB Restrains Group 2 Innate Lymphoid Cells and Type 2 Immune Pathology in Vivo.

Emerging therapy options may help patients with RAG deficiency, especially those with severe immune dysregulation

Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences

RAG2 Abolishes RAG1 Aggregation to Facilitate V(D)J Recombination.

The RAG1 N-terminal region regulates the efficiency and pathways of synapsis for V(D)J recombination

T Cell Receptor-Independent Basal Signaling via Erk and Abl Kinases Suppresses RAG Gene Expression

Generation of ROR gamma t(+) Antigen Specific T Regulatory 17 Cells from Foxp3(+) Precursors in Autoimmunity

RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches

The transcription factor ROR alpha preserves group 3 innate lymphoid cell lineage identity and function

Differential Role of Id2 in the Group 3 Innate Lymphoid Cells for the Development of Different Gut Associated Lymphoid Tissues

Innate lymphoid cells — how did we miss them?

Retinoid X Receptor Gamma Dictates the Activation Threshold of Group 2 Innate Lymphoid Cells and Limits Type 2 Inflammation in the Small Intestine.

RORγt up-regulates RAG gene expression in DP thymocytes to expand the Tcra repertoire

The RAG cell line defines a new complementation group of MHC class II deficiency

Immune Homeostasis Enforced by Co-Localized Effector and Regulatory T Cells

Suppression of lethal autoimmunity by regulatory T cells with a single TCR specificity